BridgeBio Pharma, Inc.

BBIO

BBIOBridgeBio Pharma, Inc. US flag

NASDAQ Global Select

63.88

USD

-1.48

- -

12.51BMarket Cap

Income Statement (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	41	8	70	78	9	222	502
+ Sales & Services Revenue	- -	- -	41	8	70	78	9	222	502
- Cost of Revenue	- -	- -	2	- -	3	3	2	4	21
+ Cost of Goods & Services	- -	- -	2	- -	3	3	2	4	21
Gross Profit	- -	- -	38	8	67	74	7	218	481
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	44	184	304	483	643	543	606	795	983
+ Selling, General & Admin	13	44	94	146	192	143	151	289	531
+ Research & Development	31	140	210	337	451	399	456	506	452
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-44	-184	-266	-474	-577	-468	-599	-577	-502
- Non-Operating (Income) Loss	- -	-14	22	31	10	16	54	-35	230
+ Interest Expense, Net	- -	1	- -	33	46	73	63	82	158
+ Interest Expense	- -	3	9	37	47	80	81	99	178
- Interest Income	- -	2	9	4	1	8	18	17	20
+ Other Non-Op (Income) Loss	- -	-15	22	-2	-36	-57	-9	-117	72
Pretax Income	-44	-169	-289	-505	-586	-485	-653	-542	-733
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	1	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-44	-169	-289	-505	-586	-485	-653	-543	-733
- Net Extraordinary Losses (Gains)	-27	-77	-56	-114	-48	-7	-20	-15	-16
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	-27	-77	-56	-114	-48	-7	-20	-15	-16
Income (Loss) Incl. MI	-17	-92	-233	-392	-539	-478	-633	-528	-717
- Minority Interest	13	39	28	57	24	3	10	8	8
Net Income, GAAP	-31	-131	-261	-449	-563	-481	-643	-536	-725
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-31	-131	-261	-449	-563	-481	-643	-536	-725
EBIT	-44	-184	-266	-474	-577	-468	-599	-577	-502
EBITDA	-44	-184	-265	-473	-571	-462	-593	-571	-497
EBITDA Margin (%)	- -	- -	-654.29	-5,734.34	-818.73	-594.56	-6,373.75	-257.45	-98.92
EBITA	-44	-184	-266	-474	-577	-468	-599	-577	-502
Gross Margin (%)	- -	- -	93.84	100	95.53	95.58	73.71	98.25	95.82
Operating Margin (%)	- -	- -	-656.41	-5,751.99	-827.12	-603.28	-6,443.56	-260.19	-100
Profit Margin (%)	- -	- -	-642.47	-5,439.74	-806.9	-619.7	-6,913.92	-241.44	-144.39
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	0.01	- -	0.01	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	1	1	6	7	6	6	5
Basic Weighted Avg Shares	92	92	105	118	144	147	163	186	192
Basic EPS, GAAP	-0.33	-1.42	-2.48	-3.8	-3.9	-3.26	-3.95	-2.88	-3.78
Basic EPS from Cont Ops	-0.47	-1.84	-2.75	-4.28	-4.06	-3.29	-4.01	-2.92	-3.83
Diluted Weighted Avg Shares	92	92	105	118	144	147	163	186	192
Diluted EPS, GAAP	-0.33	-1.42	-2.48	-3.8	-3.9	-3.26	-3.95	-2.88	-3.78
Diluted EPS from Cont Ops	-0.47	-1.84	-2.75	-4.28	-4.06	-3.29	-4.01	-2.92	-3.83

Balance Sheet (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	97	445	569	643	889	549	478	721	798
+ Cash, Cash Equivalents & STI	92	436	546	607	837	472	435	681	587
+ Cash & Cash Equivalents	92	436	364	356	394	377	376	681	570
+ ST Investments	- -	- -	182	251	443	95	59	- -	17
+ Accounts & Notes Receiv	- -	- -	3	- -	20	17	2	5	139
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	2	5	139
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	3	- -	20	17	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	27
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	27
+ Other ST Assets	5	9	20	36	32	60	41	35	44
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	1	20	63	61	124	74	69	199	138
+ Property, Plant & Equip, Net	- -	1	6	37	46	25	20	13	14
+ Property, Plant & Equip	- -	2	6	37	46	25	20	13	14
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	17	31	- -	- -	- -	- -	144	80
+ LT Investments	- -	17	31	- -	- -	- -	- -	144	80
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	1	26	24	78	49	49	42	45
+ Total Intangible Assets	- -	- -	- -	- -	45	29	26	24	28
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	45	29	26	24	28
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	1	26	24	33	20	23	18	17
Total Assets	98	465	632	704	1,013	623	546	919	936
+ Payables & Accruals	7	26	35	55	93	78	76	77	187
+ Accounts Payable	2	14	9	9	12	12	11	10	36
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	5	12	26	46	81	67	66	67	150
+ ST Debt	- -	- -	8	5	5	4	4	5	6
+ ST Borrowings	- -	- -	- -	1	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	4	5	4	4	5	6
+ Other ST Liabilities	1	7	17	35	37	39	63	73	95
+ Deferred Revenue	- -	- -	- -	- -	- -	8	6	15	7
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	1	7	17	35	37	31	57	58	88
Total Current Liabilities	9	33	60	96	135	121	144	154	288
+ LT Debt	- -	55	92	491	1,721	1,720	1,736	1,726	1,856
+ LT Borrowings	- -	55	92	476	1,704	1,708	1,727	1,721	1,852
+ LT Finance Leases	- -	- -	- -	15	17	12	9	5	4
+ Other LT Liabilities	144	- -	4	10	22	27	9	496	868
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	4	496	868
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	144	- -	4	10	22	27	6	- -	- -
Total Noncurrent Liabilities	144	55	95	500	1,743	1,747	1,745	2,223	2,725
Total Liabilities	153	88	156	596	1,878	1,868	1,889	2,377	3,013
+ Preferred Equity and Hybrid Capital	1	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	3	494	848	1,021	842	939	1,481	1,903	2,058
+ Common Stock	3	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	- -	494	848	1,021	842	939	1,481	1,903	2,058
- Treasury Stock	- -	- -	- -	75	275	275	275	275	323
+ Retained Earnings	-61	-179	-440	-889	-1,437	-1,918	-2,561	-3,096	-3,821
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-58	315	408	58	-870	-1,255	-1,354	-1,468	-2,087
+ Minority/Non Controlling Interest	3	62	68	50	5	10	12	10	10
Total Equity	-55	377	476	108	-866	-1,245	-1,343	-1,458	-2,077
Total Liabilities & Equity	98	465	632	704	1,013	623	546	919	936
Shares Outstanding	120	120	124	123	147	151	175	190	195
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	18	22	16	13	9	10
Net Debt	-92	-382	-272	121	1,310	1,331	1,351	1,040	1,282
Net Debt to Equity	168.23	-101.12	-57.14	112.37	-151.35	-106.91	-100.62	-71.37	-61.75
Tangible Common Equity Ratio	-56.63	81.16	75.35	15.33	-94.08	-214.3	-263.21	-165.46	-231.8
Current Ratio	11.36	13.67	9.42	6.72	6.58	4.52	3.32	4.67	2.77
Cash Conversion Cycle	- -	- -	-1,632.35	- -	-1,220.71	-1,245.83	-1,623	-948.73	109.97

Cash Flow Statement (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-44	-169	-289	-505	-586	-485	-653	-543	-733
+ Depreciation & Amortization	- -	- -	1	1	6	7	6	6	5
+ Non-Cash Items	2	10	45	89	87	30	114	-15	333
+ Stock-Based Compensation	2	6	21	58	100	92	109	96	133
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	13	- -	- -	- -
+ Other Non-Cash Adj	- -	4	24	31	-12	-74	5	-112	200
+ Chg in Non-Cash Work Cap	1	22	-11	15	-4	28	5	32	-51
+ (Inc) Dec in Accts Receiv	- -	- -	-3	3	-20	15	15	-3	-135
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	-25
+ (Inc) Dec in Prepaid Assets	-4	-6	-11	-7	-4	8	-3	-14	-9
+ Inc (Dec) in Accts Payable	5	29	20	25	36	-15	1	27	57
+ Inc (Dec) in Other	- -	-1	-17	-6	-16	20	-8	22	61
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-40	-137	-254	-400	-498	-419	-528	-521	-446
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	-18	-3	-8	-48	-6	-1	-9	-10
+ Acq of Fixed Prod Assets	- -	-2	-3	-8	-13	-5	-1	-1	-1
+ Acq of Intangible Assets	- -	-16	- -	- -	-35	-2	- -	-8	-8
+ Cash (Repurchase) of Equity	- -	96	366	-76	-205	3	443	307	-63
+ Increase in Capital Stock	- -	96	366	- -	- -	5	450	315	- -
+ Decrease in Capital Stock	- -	- -	- -	-76	-205	-2	-7	-8	-63
+ Net Change in LT Investment	- -	- -	-213	-39	-166	339	56	44	-17
+ Dec in LT Investment	- -	- -	- -	249	477	533	193	158	11
+ Inc in LT Investment	- -	- -	-213	-288	-643	-193	-137	-114	-28
+ Net Cash From Acq & Div	- -	-3	- -	- -	- -	- -	-1	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	-3	- -	- -	- -	- -	-1	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	-2	-7	14	120	- -	26	2
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	-21	-217	-53	-201	453	54	61	-24
+ Dividends Paid	-1	- -	-1	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	4	56	37	550	1,080	-20	- -	-23	116
+ Cash From Debt	4	57	37	550	1,204	- -	- -	450	575
+ Repayments of Debt	- -	-1	- -	- -	-124	-20	- -	-473	-459
+ Other Financing Activities	110	350	-3	-27	-138	4	9	465	306
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	113	502	399	447	736	-13	452	748	359
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	72	344	-72	-6	38	21	-22	289	-111
EBITDA	-44	-184	-265	-473	-571	-462	-593	-571	-497
EBITDA Margin (%)	- -	- -	-654.29	-5,734.34	-818.73	-594.56	-6,373.75	-257.45	-98.92
Free Cash Flow	-41	-155	-256	-407	-546	-426	-529	-530	-456
Net Cash Paid for Acquisitions	- -	3	- -	- -	- -	- -	1	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-83	-219	143	568	-445	-529	-545	-331
Free Cash Flow per Basic Share	-0.44	-1.68	-2.44	-3.45	-3.78	-2.89	-3.25	-2.85	-2.38
Price/Free Cash Flow	- -	- -	-14.68	-21.39	-5.35	-2.72	-12.48	-9.98	-33.58
Cash Flow to Net Income	1.32	1.05	0.97	0.89	0.89	0.87	0.82	0.97	0.62
Capital Expenditures	- -	-18	-3	-8	-48	-6	-1	-9	-10